Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Burtness

Showing results (61-70 of 184) with videos related to

Pageof 19
Sort By:
Journal of Oncology|February 20, 2010
Head and neck cancerAmanda Psyrri, Barbara Burtness, Paul M Harari, et al.
Science Signaling|December 13, 2012
Comment on "epidermal growth factor receptor is essential for toll-like receptor 3 signaling"Barbara Burtness, Shanthi Marur, Julie E Bauman, et al.
Head & Neck|February 4, 2012
Unilateral neck therapy in the human papillomavirus ERA: accepted regional spread patternsThomas J Galloway, Miriam N Lango, Barbara Burtness, et al.
Cancer Medicine|October 17, 2015
National treatment patterns in patients presenting with Stage IVC head and neck cancer: analysis of the National Cancer DatabaseZachary G Schwam, Barbara Burtness, Wendell G Yarbrough, et al.
Oral Oncology|October 23, 2021
Brachytherapy and non-cancer mortality in patients with oral cavity and oropharynx SCCsJovian Yu, Cynthia Tsay, Clarence Sasaki, et al.
Oral Oncology|June 19, 2018
National treatment times in oropharyngeal cancer treated with primary radiation or chemoradiationElliot Morse, Benjamin Judson, Zain Husain, et al.
Ophthalmic Plastic and Reconstructive Surgery|May 3, 2022
Cemiplimab for Orbital Squamous Cell Carcinoma in 11 CasesBenjamin Steren, Barbara Burtness, Aarti Bhatia, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|September 17, 2011
Protein-intrinsic and signaling network-based sources of resistance to EGFR- and ErbB family-targeted therapies in head and neck cancerRanee Mehra, Ilya G Serebriiskii, Roland L Dunbrack, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|August 1, 2018
Treatment Delays in Primarily Resected Oropharyngeal Squamous Cell Carcinoma: National Benchmarks and Survival AssociationsElliot Morse, Benjamin Judson, Zain Husain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2003
Epidermal growth factor receptor, p53 mutation, and pathological response predict survival in patients with locally advanced esophageal cancer treated with preoperative chemoradiotherapyMichael K Gibson, Susan C Abraham, Tsung-Teh Wu, et al.
Pageof 19

Showing results (61-70 of 184) with videos related to

Sort By:
Pageof 19
Journal of Oncology|February 20, 2010
Head and neck cancerAmanda Psyrri, Barbara Burtness, Paul M Harari, et al.
Science Signaling|December 13, 2012
Comment on "epidermal growth factor receptor is essential for toll-like receptor 3 signaling"Barbara Burtness, Shanthi Marur, Julie E Bauman, et al.
Head & Neck|February 4, 2012
Unilateral neck therapy in the human papillomavirus ERA: accepted regional spread patternsThomas J Galloway, Miriam N Lango, Barbara Burtness, et al.
Cancer Medicine|October 17, 2015
National treatment patterns in patients presenting with Stage IVC head and neck cancer: analysis of the National Cancer DatabaseZachary G Schwam, Barbara Burtness, Wendell G Yarbrough, et al.
Oral Oncology|October 23, 2021
Brachytherapy and non-cancer mortality in patients with oral cavity and oropharynx SCCsJovian Yu, Cynthia Tsay, Clarence Sasaki, et al.
Oral Oncology|June 19, 2018
National treatment times in oropharyngeal cancer treated with primary radiation or chemoradiationElliot Morse, Benjamin Judson, Zain Husain, et al.
Ophthalmic Plastic and Reconstructive Surgery|May 3, 2022
Cemiplimab for Orbital Squamous Cell Carcinoma in 11 CasesBenjamin Steren, Barbara Burtness, Aarti Bhatia, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|September 17, 2011
Protein-intrinsic and signaling network-based sources of resistance to EGFR- and ErbB family-targeted therapies in head and neck cancerRanee Mehra, Ilya G Serebriiskii, Roland L Dunbrack, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|August 1, 2018
Treatment Delays in Primarily Resected Oropharyngeal Squamous Cell Carcinoma: National Benchmarks and Survival AssociationsElliot Morse, Benjamin Judson, Zain Husain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2003
Epidermal growth factor receptor, p53 mutation, and pathological response predict survival in patients with locally advanced esophageal cancer treated with preoperative chemoradiotherapyMichael K Gibson, Susan C Abraham, Tsung-Teh Wu, et al.
Pageof 19